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Exposure to radioactive particles made up
of radionuclides from fission or activation
reactions and/or actinides with activities up
to millions of becquerels, also called hot
particles, has been identified as an impor-
tant radiological health problem in the
nuclear power industry. For example, the
Chernobyl nuclear power plant accident
caused extensive global radioactive fallout
which exposed millions of people to both
volatile and nonvolatile radionuclides. It
has been estimated that the fallout exposed
the population of Europe to a dose of 0.2
mSv in the first year (1); the worldwide,
average, annual effective dose from natural
sources is estimated to be 2.4 mSv (2).
However, approximate global dose esti-
mates can never predict health effects of
radioactive fallout composed of several
radionuclides with different physicochemi-
cal properties. The Chernobyl fallout had a
special feature, different from the earlier
observed nuclear reactor accidents: it con-
tained extensive amounts of pulverized
nuclear fuel from the reactor which first
exploded and then burned for several days.
The nuclear fuel particles were composed of
uranium and its nonvolatile fission prod-
ucts, including the R-emitters zirconium-95
(95Zr), niobium-95 (95Nb), ruthenium-103
('03Ru), 106Ru, cerium-141 (141Ce), and
144Ce (3-8).
Accidental exposure to nuclear fuel par-
ticles can occur via inhalation, ingestion, or
via direct skin contamination. Due to the
poor water-solubility of actinide particles,
such as uranium oxide (UO2) and plutoni-
um oxide (PuO2) particles, and consequent-
ly a low intake ofthe particles in the body,
the most important organs or tissues from
the radiobiological point of view are the
lungs, the gastrointestinal tract, and skin.
Knowledge about the biokinetic properties
ofnuclear fuel particles, in addition to the
knowledge about the biological effects of
these unique radiation sources, is essential
in risk assessment of the health effects of
the fuel particles.
Exposure to insoluble radioactive parti-
cles often leads to an exposure situation
where only a minor fraction of the target
tissue or organ is irradiated due to a short
range of a- and f-irradiation (from a few
microns to a few millimeters).. The biologi-
cal effects of nonuniform radiation expo-
sure compared to uniform radiation expo-
sure have been investigated in a number of
theoretical and experimental studies for
nearly three decades. The so-called "hot
particle hypothesis" is based on the
assumption that a nonuniformly distrib-
uted radiation dose is more carcinogenic
than an equal radiation dose delivered uni-
formly to the same organ or tissue (9,10).
The hypothesis was originally based on the
effects of a-radiation. This hypothesis has
repeatedly been refuted by many theoreti-
cal and experimental studies (11-15). As a
consequence ofthe Chernobyl power plant
accident, several theoretical and experi-
mental studies coordinated by the
International Atomic Energy Agency were
initiated to study possible health hazards
associated with the exposure to {3-emitting
hot particles (16). Recent experimental
studies indicate that conventional dose risk
assessment models may underestimate the
biological significance of {-emitting hot
particles (17-21).
The primary aim of this overview is to
describe the biokinetic properties ofinsolu-
ble nuclear fuel compounds and the effects
ofnonuniform radiation exposure. First, we
summarize data on hot particles, including
sources, dosimetry, and human exposure.
Second, data on the absorption, distribu-
tion and elimination of insoluble actinide
particles in the gastrointestinal tract and
respiratory tract, with special reference to
insoluble U02 and PuO2 particles, and
nonvolatile, long-lived f9-emitters Zr, Nb,
Ru, and Ce are presented. Finally, we dis-
cuss short- and long-term biological effects
ofnonuniform a- and f3-irradiation on the
gastrointestinal tract, lungs, and skin.
Hot Particles
Sources
A hot particle is defined [applied to skin
according to the National Council on
Radiation Protection (14)] as a discrete
radioactive fragment with a high specific
activity (up to millions of Becquerels),
insoluble in water, and not larger than
approximately 1 mm in any dimension.
Hot particles emit a-radiation, g-radiation,
or /y-radiation. Natural uranium contains
0.7% of the fissionable uranium isotope
235U (22). This natural isotope ofuranium
is is currently the primary fuel used in
nuclear power plants. Other fissionable
nuclear fuels are239Pu and 233U.
Both pressurized water reactors and
boiling water reactors can cause hot particle
contamination in the nuclear power plant
environment (23). The particles usually
contain activation products, such as 60Co,
or fission products of uranium. Activation
product particles originate mainly from the
high-cobalt stellite used in valve seats.
Fission product particles are mainly released
after failures in the nuclear fuel processes.
The radioactivity of the 60Co particles
ranges from 40 Bq to 20 MBq with size
range between a few microns and several
millimeters. The radioactivity of fission
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products containing particles ranges from
40 Bq to 400 kBq with the same size range
(24). In the United States, after examina-
tion of61 nuclear power stations, 44 high-
activity hot particles were found (25). The
particles were both activation (metallic par-
ticles) containing mainly 60Co with a size
range from several microns to several mil-
limeters, activities from 37 Bq to 37 MBq,
and fission and fuel activation products
with sizes and activities nearly ofthe same
order. Mandjukov et al. (26) also found
high-activity hot particles (85% activation,
15% fuel fragments) in the Kozloduy
nuclear power plant in Bulgaria in 1992.
Hot particles containing a-emitters
have been observed in the effluent from
nuclear fuel reprocessing plants. For exam-
ple, the effluent from the Sellafield repro-
cessing plant in the UK (27) has been
found to contain small quantities ofthe a-
emitting transuranium elements neptuni-
um (Np), Pu, americium (Am), and curi-
um (Cm) (28). Similar particles have been
found in environmental samples taken near
the plant.
The most important anthropogenic
source for environmental radiation is
nuclear weapons testing in the atmosphere
(27). Carbon-14 is the main contributor to
the dose, i.e., 2.6 mSv to the population in
the north temperate zone, whereas the dose
from fission products and plutonium is
only 0.6 mSv (27). f-emitting hot particles
isolated in the fallout of nuclear weapon
tests had a mean geometric diameter of
about 4 pm and a total activity up to 100
Bq. The main part of the particles con-
tained the following components:
95Zr/95Nb, molybdenum-99 (99Mo), 131I,
tellurium-132 (132Te)/1321), barium-140
(140Ba)/lanthanum (140La), 14ICe, and
neodymium (147Nd) (29).
Nuclear fallout from nuclear reactor
accidents can contain both volatile, such as
l37Cs and 1311, and nonvolatile fission
products of uranium. The Chernobyl fall-
out in 1986 contained all nonvolatile fis-
sion products, including the g-emitters
95Zr, 95Nb, 103Ru, 10kRu, 14ICe, and
144Ce attached to uranium matrix (Table
1) (3-6). The total release was estimated to
290 PBq. About 50% of the releases were
cesium isotopes, and 43% were nonvolatile
fission products, whereas only 1.8% ofthe
fallout was composed of plutonium iso-
topes (27). Hot particles in the Chernobyl
fallout had a geometric diameter ranging
from a few microns (Finland) to about 100
pm (Kiev). The total activity of the parti-
cles varied between about 30 Bq (average
activity 130 Bq in Finland) (5,6) to over
1000 kBq (Poland) (8). Hot particles were
also observed in the fallout from a nuclear
incident in 1992 at the power plant in
Sosnovyi Bor, Russia (30). Gases and a
small amount ofcerium and zirconium iso-
topes containing nuclear fuel particles were
identified in the surface air in Finland.
Dosimetry
An a-active hot particle emits radiation
which only penetrates up to 100 pm in a
biological tissue. For example, the absorbed
dose rate in a simulated tissue-equivalent
object at the distance of 10 pm from a 1
Bq 241Am source (average a-energy, 5.4
MeV) is about 70 Gy/hr, whereas at the
distance of40 pm, it decreases to about 2
Gy/hr (31). The radiation dose in the
immediate vicinity of the a-active particle
is very high and would be expected to kill
most ofthe cells exposed to the radiation.
The range ofa C-radiation in a biologi-
cal tissue can be in the order of a few mil-
limeters depending on the f-energy. A f-
emitting hot particle creates a dose gradient
around it, causing cell death near the parti-
cle. The cells around the lethal zone obtain a
sublethal dose, which does not kill the cells
but is large enough to cause a random,
malignant transformation (17-21). In
Figure 1, a dosimetric model for a hot parti-
cle containing 1000 Bq of106Ru or 14 Ce is
shown. For example, at the distance of 1
mm from the particle, the radiation dose
rate is 0.01 Gy/hr, and at the distance of0.2
mm, the dose rate is about 1 Gy/hr (5).
PoIlanen and Toivonen (32) have calculated
skin doses from large uranium fuel particles.
The nuclide composition of the particles
was estimated from the inventory of the
Chernobyl reactor. For example, a uranium
nuclear fuel particle ofsize 40 pm, deposited
on the skin, can cause a dose of 1.6 Gy/cm2.
Hofmann et al. (33) calculated radiation
doses and lung cancer risk for a hot particle
composed entirely of 103Ru. The authors
concluded that in the immediate vicinity of
a particle the doses are so high that all cells
are killed and no tumors will arise. At inter-
mediate distances, the probability for lung
cancer induction exhibits a distinct maxi-
mum. According to the ICRP (34), inhala-
tion ofa 300 Bq (geometric diameter 1 pm)
103Ru hot particle results in an average lung
dose of3.2 x 10-2 mGy/year. Burkart (35)
concluded that the limited knowledge on
the biological response ofaffected tissue and
the limited experimental and epidemiologi-
cal database for f-active hot particles
requires additional information to elucidate
the main characteristics of lung irradiation
byhot particles.
The hot particle hypothesis was proposed
by Geesaman (9) and Tamplin and Cochran
(10). Itimplied thathighly nonuniform radi-
ation, for example on the skin or lungs,
Table 1. Physical data of nonvolatile fission prod-
ucts in an average hot particle (activity 130 Bq,
aerodynamic size 10 pm) found following the
Chernobyl fallout in Finland (6)
Physical
Radionuclide tl12 (days)
Cerium-144 285
Cerium-141 32
Ruthenium-103 39
Ruthenium-106 368
Zirconium-95 64
Niobium-95 35
aDaughter nuclide 144Pr.
bDaughter nuclide 106Rh.
Activity
(Bq)
21.5
26.7
23.2
5.42
27.5
25.8
Average
1-energy
(MeV)
1.208a
0.144
0.062
1.415b
0.115
0.046
might be five orders of magnitude more
harmful than uniform radiation. Most ofthe
theoretical (12,14,15) and experimental
studies (see Table 3) have refuted the hot
particle hypothesis. However, we have
observed that hot particle-induced carcino-
genesis is associated with specific biological
mechanisms that cannot be explained by
mathematical modeling (17-21).
Human Exposure
Occupational exposure. Within nuclear
power plants, hot particles may be attached
to the workers due to electrical charges
inherent in the plastic protective clothing
worn by nuclear power plant workers (23).
A high-activity hot particle can cause con-
siderable local skin doses to exposed
employees (25). Hot particles can also
deposit on conjunctival tissue ofworkers,
such as in the eye (36). Fuel cladding failure
events may increase radiation exposure rates
by an estimated 540% in some areas ofthe
nuclear power plant during routine opera-
tions (37).
McInroy et al. (38) have reported a
whole-body distribution of 239Pu in an
occupationally exposed worker. The work-
er was involved in operations with plutoni-
um exposure from 1945 to 1982, approxi-
mately 10.5 months before his death. At
the time of death the body contained 246
Bq of239Pu, ofwhich 52.8% was found in
the lungs and associated lymph nodes. The
remaining 47.2% was mostly in the skele-
ton (44%), the liver (42%), with the
remainder (14%) in the rest of the body.
Studies on the 42-year follow-up of 26
Manhattan Project plutonium workers esti-
mated that the plutonium depositions,
including lung burdens, range from 52 to
3180 Bq with a median value of 500 Bq
(39).
Health effects ofa-active hot 239Pu par-
ticles have been investigated in a few epi-
demiologic studies (39,41-44). The
exposed populations have either been work-
ers in nuclear weapon facilities or workers
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accidentally exposed. The results have not
shown any excess mortality or cancer inci-
dence among the exposed persons.
Chernobylfallout. Particulate fallout
from Chernobyl extended over 1000 km
from the accident site (3-5), exposing mil-
lions of people. In the vicinity of the
Chernobyl nuclear power plant, a large
number of people were exposed to both
external y-irradiation and highly penetrating
{3-irradiation from pulverized nuclear fuel,
which was mainly deposited on the skin.
The total number of the victims was 237;
140 persons were exposed to between 1 and
2 Gy, and 97 to between 2 and 8 Gywhole-
body doses (45). All patients with total body
doses higher than 4 Gy had skin burns. The
1-emitters were deposited on the skin and
clothes of the victims and caused severe
burns (45,46) that often led to their deaths.
In more distant areas from the accident
site exposure to hot particles occurred main-
ly via ingestion or inhalation. For example,
the plutonium body contents ofGomel citi-
zens in Russia, 4-5 years after the
Chernobyl accident, were on average 3-4
times higher than the global levels (40). In
Poland, the estimated annual intake ofplu-
tonium in the diet was 774 mBq/year in the
first year after the Chernobyl accident and
decreased to approximately 90 mBq/year in
the sixth year (47). Lung doses in farmers
living in the 30-km isolated zone around
the power plant were estimated to be ofthe
order ofseveral milliSieverts during the first
year after the accident (48). The number of
hot particle-induced lung cancer cases for
the Bulgarian population was estimated as
four to six, or approximately 10% of the
total number oflung cancer cases which are
expected from external and internal irradia-
tion after the Chernobyl accident (49).
Balashazy et al. (7) estimated the- lung can-
cer risk due to inhalation of Chernobyl-
released hot particles to be less than 10-10
for individuals living in Budapest. In
Finland, the epidemiological studies have
focused on the fallout and incidence of
childhood leukemia (50). However, human
exposure to the Chernobyl hot particles has
not been verified experimentally. In Finland
as a whole, no increase in the incidence of
childhood leukemia was observed from
1976 to 1992. However, some indication of
an increase in the incidence of the disease
was observed in the area with the highest
exposure based on one or two extra cases per
year.
Biokinetics of Nuclear Fuel
Compounds in the
Gastrointestinal Tract
Radionuclides can be ingested either by
direct intake ofcontaminated food or water
or by swallowing inhaled material that has
been cleared from the respiratory tract.
Radionuclide absorption can occur from all
segments of the gastrointestinal (GI) tract.
The small intestine is generally the primary
site ofsystemic uptake due to the large sur-
face area of villus. Water-insoluble
radionuclides that are not absorbed during
GI transport or those that are first absorbed
then subsequently secreted into the GI
lumen and not reabsorbed are primarily
excreted in feces. The excretion rate may
vary greatly even within the same animal
population because of unusual evacuation
habits or unexplained physiological differ-
ences, for example (51).
Behavior of particulate material in the
GI tract is affected by many factors. For
example, large insoluble particles appear to
pass through the tract more slowly than
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much smaller particles ingested in solution
(51). Solid particles may be absorbed via
phagocytosis through Peyer's patches into
lymph (52). Peyer's patches are lymphoid,
follicular aggregates on the intestinal
mucosa. Another mechanism of particle
uptake is persorption (53), which means that
as epithelial cells are sloughed offat the tip
ofthe villus, a gap in the membrane is tem-
porarily created, allowing entry of materials
that are not membrane permeable. There is
evidence for and against the persorption
hypothesis (54). A third mechanism for par-
ticle transport is epithelial membrane dam-
age. Absorption ofparticles can be enhanced
after exposure to certain chemicals (52).
Actinides
Human data show that the actinide ele-
ments thorium (Th), Np, Pu, Am, and Cm
0 1 2 3 4 5 6 7
Distance(mm)
Figure 1. Radiation dose rate from a hot particle containing 1000 Bq of ruthenium-106 or cerium-144 and
daughter nuclides rhodium-106 and praseodymium-144.
Volume 103, Number 10, October 1995 * EnvironmentalHealth Perspectives 922Reviews * Biokinetics and effects ofnuclear fuel particles
are absorbed poorly from the GI tract (55).
The values for their fractional absorption
are 2 x 10-4 (10-4 for Am). The gastroin-
testinal absorption of uranium is greater
than that seen with the other actinides.
This is consistent with its different solution
chemistry. Uranium also behaves different-
lywithin the body, with a low intake in tis-
sues other than bone. Uranium is primarily
excreted via urine with associated retention
in the kidneys (56). The average human GI
absorption ofU is most likely 1-2% and is
probably independent ofage or the mass of
U ingested (57). Chemical and biological
data for U and Pu are shown in Table 2.
In animal experiments, factors affecting
the GI absorption ofactinides, and particu-
larly Pu, have been studied extensively.
Values offractional absorption in newborn
animals, depending on the chemical form
ofthe compound, vary between 10-2 and 3
x 10-5 (55). Values for adult animals are
somewhat lower: between 10-3 and 3 x 10-5.
Oxides ofPu have very low absorption val-
ues, typically <10-5. Fritsch et al. (58) have
shown that absorption in neonatal rats is
limited mainly to the first hours after
ingestion, whereas in guinea pigs and pri-
mates, ingested Pu was retained in
macrophages located beneath the intestinal
epithelial cells. In neonatal primates,
increased absorption appears to be due to
uptake in distal epithelial cells. Higher val-
ues of absorption of many elements have
been observed in fasted animals.
Absorption of plutonium can be increased
by an order ofmagnitude in fasted animals
(59). This is presumably due to decreases
in concentration of binding ligands which
normally act as direct competitors for
absorption.
Fractional absorption ofU in hamsters,
rabbits, dogs, and baboons is in the range
of 3 x 10-3 to 2 x 10-2, i.e., somewhat
lower than for humans (57). Absorption
values for rats are usually lower; values as
low as 4 x 10-4 have been reported. The
normal U content of a reference man is
about 38 pg, ofwhich 66% is found in the
skeleton (57. The natural U concentration
in the human kidney (0.3% of the total
body burden) appears to be about twice
that in the liver. When U is injected subcu-
taneously or intravenously, accumulation
primarily occurs in the kidneys or bones
(56). Uranium competes with calcium for
sites of deposition. Neutron-induced
autoradiographs of retained U in human
bones show that under equilibrium condi-
tions it is diffusively distributed through-
out the bone volume (57. Uranium diox-
ide, U02, with a melting point of 2078 ±
20'C, is water-insoluble but soluble in
HNO and concentrated H2SO4 (60). The
rate odissolution ofU02 in acids depends
on the particle size, acid concentration, and
temperature (61). Hodge and co-workers
[see Yuile (56)] conducted 1- and 2-year
feeding experiments in rats and observed
that U02 was not absorbed by the GI tract.
The chemical analyses showed no increase
in the U content in the kidneys or bone.
Fission Products
Zr, Nb, and Ru belong to the transition
metals and Ce to the inner transition met-
als (also called lanthanides or rare earths).
These metals are water-insoluble in their
dioxide form (60). Several experiments
have been performed to study GI absorp-
tion of these uranium fission products in
laboratory animals (34,62). The chemical
and biological characteristics of these
nuclides are shown in Table 2. The gener-
ally accepted values offractional absorption
for Zr, Nb, and Ce are less than 10-4 and 3
x 10-2 for Ru. The values are based on the
studies with single nuclides in ion salts
(e.g., chlorides, oxalates, and nitrates) (34).
GI absorption of 95Nb oxalate in the
mouse, rat, and monkey is approximately
1% (63). In young rats, the whole body
retention of 141Ce nitrate is less than
0.04%, and absorption of various salts of
95Zr/95Nb is approximately 0.8% (64). In
miniature swine, a whole-body retention of
144Ce chloride ofless than 0.01% has been
reported (65). GI absorption of 95Nb cit-
rate in guinea pigs has been estimated as
0.8% (66).
A few studies have shown that whole-
body retention of 95Zr, 95Nb, 141Ce, and
144Ce is significantly higher in suckling
than in adult rats (67-69). The absorption
Table 2. Chemical and biological data of uranium, plutonium, and nonvolatile uranium fission products
(60,63)
Fractional Fractional Biological
absorption absorption t1,2(days),
Element Solubility in dioxide form by ingestion by inhalation total body
Uranium Insoluble in H20;soluble in HNO3, conc. H2S04 <10-4 0.25 100
Plutonium Insoluble in H20; soluble in conc. H2SO4, HNO3, HF 3 x 10-5 0.25 6.5 x 104
Cerium Insoluble in H20; soluble in H2S04, HNO3 <10-4 0.25 563
Ruthenium Insoluble in H20, alkali; soluble in fused alkali 0.03 0.27 7.3
Zirconium Insoluble in H20; soluble in H2SO4, HF <10-4 0.25 450
Niobium Insoluble in H20, alkali; slightly soluble in alkali <10-4 0.25 760
can be 10-100 times higher in neonates.
This relative increase in absorption is
probably due to retention of the radionu-
clides in the intestine where pinocytosis is
more active in younger animals. For exam-
ple, insoluble radionuclides such as cerium
and niobium are readily taken up by the
intestinal cells in suckling rats and are
apparently immobilized in these cells and
are cleared from the body only when the
cells have migrated up to the villi and have
been sloughed into the intestinal lumen
(68). Increased absorption of ingested
radionuclides in neonates is a general phe-
nomenon (66) that is observed immediate-
ly after birth, followed generally by a pro-
gressive reduction over the suckling period
(70). The absorption appears to be non-
specific due to a greater permeability of
the immature intestine for different ele-
ments and range ofmolecular species. This
phenomenon may be related to the specific
uptake of immunoglobulins from milk,
which continues to a reduced extent after
"closure" ofthe intestine to the transfer of
these molecules (71). Intestinal retention
of 95Nb citrate in newborn guinea pigs is
low, unlike retention in other species (66),
but consistent with observations of the
retention of actinide elements in this
species (71). In the guinea pig, as in
humans, this "closure" occurs either before
or shortly after birth; maternal
immunoglobulins are transferred cross-pla-
centally to the fetus, and the mechanism of
intestinal uptake from milk does not oper-
ate (72). Fasting results in a 75% increase
in niobium absorption in guinea pigs (fast-
ing 24 hr and 2 hr after the administra-
tion) (66).
Distribution studies with ion salts of
95Zr, 95Nb, 103Ru, and 144Ce in different
animals species have shown that these
radionuclides are primarily deposited in the
bone both after oral and intravenous
administration (63,69,73). Some uptake
also occurs in the liver, kidney, spleen, and
testis. Ruthenium, however, does not accu-
mulate as strongly in bone as other
radionuclides (73).
The fission products have entirely dif-
ferent biokinetic properties when adminis-
tered in particulate form. Lang and
Raunemaa (74) studied the behavior of
simulated nuclear fuel particles in the GI
tract of the rat. Whole-body autoradiogra-
phy and y-spectrometric tissue analIyses
showed no absorption of 141Ce, 14 Ce,
103Ru, 95Zr, or 95Nb from the GI tract.
None ofthe radionuclides could be detect-
ed in the liver, kidney, muscle, bone, brain,
blood, or urine. Approximately 98% ofthe
total radioactivity was excreted in feces
within 3 days post-exposure. Intestinal
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retention for 141Ce, 144Ce, 103Ru, and 95Zr
at 1 day after administration was between 2
and 3%; for 95Nb retention it was about
6%. These results indicated that U02 fis-
sion products must first be released from
the matrix of particles prior to absorption
of nuclides across the intestinal mucosa.
This is also supported by the observations
of Mirell and Blahd (75) who performed
whole-body measurements of an American
tour group who were exposed in Kiev to
the initial Chernobyl reactor accident
plume. They found that ingestion of par-
ticulate fission products (141Ce, 144 Ce,
1311, 103Ru, 137Cs, 95Zr/Nb) appeared to
result in a relatively short element-indepen-
dent retention. Consequently, fission prod-
ucts in the fused particulate form renders
them virtually inert in metabolic terms and
the radionuclides are not metabolized
along biological pathways characteristic for
the elementary form (34). Ingestion of
nuclear fuel particles does not lead to sig-
nificant extraction offission products from
particles and their deposition into tissues
where they may be retained for long peri-
ods oftime.
Effects of Nuclear Fuel
Compounds on the
Gastrointestinal Tract
The toxicity of poorly absorbed, ingested
radionuclides depends on the energy ofthe
nuclide, the mass ofthe intestinal contents,
and how long the nuclide remains in the
gastrointestinal tract. The high rate of cell
proliferation in the small intestine makes
this tissue especially sensitive to ionizing
radiation (76,77). The most radiosensitive
cells in the intestine are the crypt cells. In
humans, the crypt cells of the duodenum
may lie 1.5 cm beneath the surface, where-
as in the rat, the distance is approximately
0.02 cm. Consequently, the biological
effects of poorly absorbed radionuclides
depend on the type of radiation (i.e., the
differences in ranges) the nuclides emit.
Sullivan et al. (78) exposed rats to the
5-emitter yttrium-91 (91Y) as the YCl3 at
925 MBq/kg (dose to large intestine about
30 Gy) and to a suspension of239PuO2 (a-
dose to the surface of the small intestine
about 1000 Gy). Exposure to 91Y caused
severe damage to the cecum and colon,
such as disruption ofthe crypt pattern, cys-
tic dilation ofthe crypts, irregularity ofthe
surface epithelium, cytoplasmic vacuoliza-
tion, and edema and hyperemia ofthe sub-
mucosa. Plutonium a-particles induced
only mild and superficial lesions confined
to the cecum and colon. The authors con-
cluded that ingested a-emitters did not
induce acute toxicity, in contrast to g-emit-
ters, because ofthe poor penetration of a-
irradiation to the radiosensitive crypt cells
(78). In contrast, in neonatal rats, acute
intestinal lesions leading to death were
observed after gavage of 238Pu (IV)-citrate
(122 kBq per animal) (79). The neonatal
rats might be more sensitive to a-irradia-
tion because they have immature and poor-
ly invaginated crypts compared to other
mammalian species (801.
Studies with insoluble 238PuO2 (81)
and simulated nuclear fuel particles
[depleted uranium in graphite matrix and
strontium-89 chloride (51)] have shown
that prolonged retention ofparticles in the
intestine produces localized pathological
lesions. In the pig intestine, 23 PuO2 parti-
cles caused villar-tip necrosis and inflam-
mation in a 1-cm region surrounding the
particles (81). In the rat, simulated nuclear
fuel particles caused partial denudation of
the epithelium and/or ulceration, and less
severe damage with changes in the architec-
tural structure in the villi and marked cel-
lular atypia in the epithelial cells (51).
Sikov et al. (51) concluded that the same
amount ofradiation administered uniform-
ly in solution would not have caused seri-
ous damage. The potential for damage
from an insoluble radioactive particle
depends on the length of time the particle
remains at a given point in its progress
through the GI tract. Sullivan et al. (76)
exposed suckling, weanling, and adult rats
by gavage and adult beagle dogs by inges-
tion to high-energy (1.4 MeV average)
106Ru-rhodium-106 (106Rh) chloride solu-
tion. The LD values for suckling, wean-
ling, and adut rats were 55,000, 666,000
and 333,000 kBq/kg, respectively. The
newborn rats were most sensitive because
of the absorption of the radionuclide into
the mucosa of the lower small intestine
where it can destroy that segment. In the
same study the low-energy fl-emitter
promethium (i47Pm) caused death in rats
by damaging the large bowel. The LD50 for
106Ru-106Rh in dogs was about 129,500
kBq/kg. The signs of intestinal injury,
duration of injury, and the probabilities of
tissue repair were much different in the dog
than in the rat (76). The midcolon and
lower colon of dogs were usually denuded
at focal sites rather than in widespread
areas.
Biokinetics of Nuclear Fuel
Compounds in the
Respiratory Tract
Inhalation is considered the most likely
route of accidental intake of radionuclides
(82). Inhalation of particles can lead to
deposition in the nasopharyngeal, tracheo-
bronchial, and pulmonary regions of the
respiratory tract. The extent of particle
deposition is a function of particle size,
shape, and density of the aerosol, lung
structure, and respiratory characteristics
such as breathing rate, tidal volume, and
expiratory reserve volume (62). It is also
well documented that anatomic and physi-
ological differences exist among experimen-
tal animals that may influence deposition
patterns (83). For example, the simulation
models for inhaled materials project an
eightfold difference among rats, guinea
pigs, dogs, and nonhuman primates in the
lung concentration ofparticles per gram of
lung after a 2-year chronic inhalation expo-
sure to the same aerosol for 8 hr/day, 5
days/week (84). The largest lung accumula-
tion would occur in guinea pigs, the small-
est in rats. Deposited particles are taken up
by endocytosis, either by phagocytosis or
pinocytosis, during the first few hours after
deposition. Particles are rapidly phagocy-
tized by pulmonary alveolar macrophages
or other phagocytic cells. Some particles
may directly enter the alveolar interstitium
by pinocytosis (84). There are also indica-
tions that the particles in the lungs are
redistributed or aggregated due to
macrophage migration and grouping (85),
which may change the radiation dose or
injury pattern. Water-insoluble radionu-
clides are absorbed in accordance with their
dissolution rate, partition coefficient, and
residence time in the respiratory tract (62).
The dominant routes for physical
translocation of particles from the pul-
monary region are the mucociliary escalator
or the lung-associated lymph system, pre-
sumably phagocytosis. In addition to
chemical dissolution of particles, physical
forces may also influence the dissolution
rate indirectly by altering the form of the
particles and the surface area available for
dissolution. Very small particles may also
be translocated directly into the circulatory
system (84). In addition, translocation of
particles into the interstitium appears to be
a function of the number of particles; i.e.,
the delivered dose and dose rate (86).
Exhalation is a major elimination pathway
for undeposited particles and gases.
Actinides
Oxides and hydroxides of actinides are
water-insoluble compounds that have maxi-
mal retention half-times in the lungs ofover
100 days (34). It has been shown that in
the rat, inhaled particulate compounds of
actinides become stored in phagolysosomes
of alveolar macrophages (87). Rat alveolar
macrophages possess the ability to phagocy-
tize U02 particles despite the high toxicity
the metal exerts on cell membranes (88).
Soluble actinides, such as 241Am(OH)3, are
solubilized within lysosomes, bind to cytoso-
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lic ferritin, and released from macrophages.
The compounds can cross the alveolar mem-
branes as transferrin or as low molecular
weight forms. Insoluble U02and PuO2 par-
tides remain within the lysosomes ofalveolar
macrophages and may damage the lysosomal
membranes. The particles can thus also be
observed free in the cytoplasm (87).
Leach et al. (89,90) exposed dogs,
monkeys, and rats in a 5-year inhalation
study to a natural uranium dioxide (UO2)
aerosol ofapproximately 1 pm mass medi-
an diameter at a mean concentration of 5
mg/m3. Biological half-times in the dog
lung and tracheobronchial lymph nodes
were 20 and 26 months, respectively. The
analogous values for monkeys were 18 and
65 months, and for rats, 10 and 22 months
respectively. Similar high lung-retention
values in these animal species have been
reported for mixed U02 and PuO2 parti-
cles (91,92). Monkeys and rats clear pluto-
nium and americium (in mixed oxide parti-
cles) from their lungs faster than dogs. The
authors concluded that errors could result
from using data from a single animal
species to estimate inhalation risk to
humans (89,90). LaBauve et al. (93)
reported that in the rhesus monkey, the
inhaled 239PuO2 was retained in the body
with an average effective half-life of 1000
days with some translocation to the pul-
monary lymph nodes. Human data suggest
that the biological half-time ofU02 in the
lung is between 500 and 1500 days (94).
Intratracheal instillation produces a
much more nonuniform distribution of
particles in the lungs than that seen after
inhalation exposure (95-97). However,
some aggregation ofU02 particles seems to
occur in the rat lung even after inhalation
due to macrophage phagocytosis, probably
as early as within 24 hr after the exposure
(85). Similar observations have been made
for PuO2 particles in different animal
species (98). Formation of large 239PuO2
aggregates (>25 particles) may produce a
mean dose rate as high as 120 Gy/day to
the focal alveolar regions (99). The aggre-
gation ofactinide particles such as uranium
dioxide is probably due to both the physi-
cal characteristics ofthe particles and active
macrophage transport.
Relatively insoluble actinide particles
which are retained in the lungs for long
periods oftime are slowly cleared mechani-
callyby mucociliary action, swallowing, and
excretion via the GI tract. Particles in the
lower airways can also be transported to the
tracheobronchial lymph nodes, or blood
and further to various tissues. Studies on
dogs have shown that the lung and lymph
nodes associated with lymphatic drainage of
the respiratory tract are the principal sites of
a-irradiation from inhaled 239PuO2 (100).
There is also evidence that various types of
particles are not completely cleared from
the large airways (101,102). For example,
up to 0.7% ofU02 particles injected in the
rat trachea can be found in the trachea 14
days after exposure (101). The mechanism
ofretention in the tracheal wall is not clear,
but probably consists of phagocytosis by
epithelial cells.
Current studies reveal that the clear-
ance half-time from the rat lung is 247
days for U02 particles with an aerodynam-
ic diameter of 2.7-3.2 pm after a single
exposure (103). Mixed (U,Pu)02 particles
appear to have a shorter biological half-
time in the rat lung compared to U02 par-
ticles but similar to PuO2 particles
(91,92,104,105) ranging from 60 to 100
days (87,102). The retention of these
mixed oxide aerosols is not significantly
influenced by particle shape or exposure
method. In the baboon, lung retention of
pure PuO2 and mixed (U,Pu)02 was
56-80% ofthe initial pulmonary burden 1
year after a single inhalation exposure (92).
Dissolution of insoluble U02 and
PuO2 particles, which has been demonstrat-
ed both in vitro and in vivo (106), appears
to be the dominant mechanical process in
lung clearance. Uranium is dissolved more
readily than Pu or Am in mixed UO2 and
PuO2 particles, generally reflecting the
physical nature of the UO2-Pu02 matrix.
Fragmentation of 238PuO2 particles has a
significant influence on the lung clearance
ofparticles (105). This phenomenon proba-
bly reflects the increased surface area ofpar-
ticles which would increase their solubiliza-
tion rate and direct transfer of nanometer-
sized particles from the lungs to various tis-
sues. Observations with PuO2 (107) and
CmO2 (108) have shown that small parti-
cles, approximately 1 nm in diameter, are
translocated intact from lungs to blood and
urine. Cooper et al. (109) have shown that
233UO2 particles <4 nm in diameter
translocate from lungs to blood at the same
rapid rate as 233UO2(NO3)2. The authors
suggested that small particles of U02 are
oxidized during the inhalation procedure to
U03, which reacts with salt solutions in the
lungs and forms the uranyl ion (109). The
uranyl ions bind to the major pulmonary
surfactant phophatidylcholine and are
translocated to blood. In plasma, approxi-
mately 50% ofthe 233U is bound to trans-
ferrin, 25% to citrate, and 25% to bicar-
bonate.
Insoluble U02 particles retained in the
lower airways are translocated poorly to
other organs. Morris et al. (103) found
82% of the total body burden of enriched
U02 in the rat lung at 720 days after expo-
sure. Ten percent ofthe activity was in the
thoracic lymph nodes, 3.9% in bone, 3.2%
in soft tissue, and 0.8% in the kidney. The
values for other organs and tissues were
below 0.1%. Similar observations have
been made with mixed (U,Pu)02 particles
(87). Only 1% of the initial alveolar
deposit was found in the rat liver, spleen,
or kidneys throughout the 200-day obser-
vation period. Lataillade et al. (92) report-
ed that translocation of mixed U02 and
PuO2 from rat and monkey lung after a
single inhalation exposure was less than 3%
of the initial pulmonary burden. The
translocation of Pu from the mixed oxide
to the skeleton and liver was greater than
that from the industrial PuO2. In mice,
only about 0.5% ofthe inhaled 239PuO2 is
translocated to other organs (110).
Fission Products
The behavior of uranium nonvolatile fis-
sion products in the lungs has not been
studied as extensively as their behavior in
the GI tract. Chemical and biological char-
acteristics of the nuclides are shown in
Table 2. The mean biological half-time of
ZrO2 in the human lung has been estimat-
ed to be 224 days, and in the beagle dog
the calculated value is 301 days (111).
Thomas et al. (112) exposed mice to 95Zr
and 95Nb in oxalic acid. The particles were
generated at four different temperatures
ranging from 100°C to 1 100°C. Over 90%
of the whole-body 95Zr and 95Nb was
retained in the lungs at the higher tempera-
tures (6000 and 1100°C) and was cleared
with a half-time of about 39 days. About
2-3% of sacrifice body burden was found
in the bone. At the lower temperatures
(1000 and 250°C) the retention half-times
were 61-62 days, and approximately 80%
of the total body burden was found in the
skeleton and 3% in the liver 120 days after
inhalation. Different metabolism of the
radionuclides was sometimes observed
depending on the temperature of forma-
tion. Zirconium was translocated more
readily to the bone than niobium. Inhaled
144CeO2 particles are also translocated
poorly from the lungs. Lundgren et al.
(113) observed that, in the rat, 91% ofthe
whole-body activity was found in the lungs
29 days after inhalation. The content in
the skeleton was 1.0% at 270 days after
inhalation, and 0.15% in the liver at 170
days after inhalation. Lang et al. (97)
exposed rats to neutron-activated UO par-
ticles, including the I3-emitters 141Ce,
144Ce, 103Ru, 9fZr, and 95Nb. At 1 day
after intratracheal instillation, on average
78.1% of the total injected radioactivity
was detected in the lungs. Only 0.7% of
the activity was found in the trachea, and
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the rest was in the gastrointestinal tract
(8.3%) and feces (12.9%). One month
after instillation, approximately 94% ofthe
retained total body activity was in the
lungs, and this decreased to 83% after 3
months. The activities in the liver, kidney,
spleen, and bone were <1% ofthe retained
total body activity. The fractional absorp-
tion in the liver and bone was significantly
lower (p <0.05) than expected (65,114),
which was probably due to the administra-
tion ofuranium fission products in particu-
late form. Clearance of uranium-matrix-
associated fission products from the lungs
is preferentially dependent on the physical
characteristics ofthe particulate material, as
previously described. Particle size is proba-
bly the most important factor in the
translocation of water-insoluble particles
from the lungs to the blood (105,
107-109).
Effects of Nuclear Fuel
Compounds on the Lungs
Short-term Effects
Deposition of insoluble radioactive parti-
cles in the alveoli is associated with an ele-
vated lung cancer risk due to the long
retention ofparticles in the lower respirato-
ry tract. However, the significance of the
short-term effects of insoluble radioactive
particles, such as inflammatory reactions,
in the development of lung neoplasms is
not well understood. High lung radiation
doses are needed to cause early mortality in
experimental animals. For example, studies
on 239PuO2 have shown that early death
occurs in baboons and dogs after accumu-
lation of lung doses between 20 and 100
Gy (15).
Alveolar macrophages represent the ini-
tial defense mechanism of the lungs for
clearing particulate matter. Although the
alveolar macrophages are not tumor precur-
sor cells, they secrete various cell growth-
related factors, such as interleukin-1, tumor
necrosis factor, and leukotrienes (116). The
high toxicity of U02 on macrophages
depends on the interaction of the metal
with phospholipids and proteins, resulting
in alterations of membrane permeability in
phagosomes. Successive events may lead to
the leakage of hydrolytic enzymes which
may in turn cause severe damage to the
cytoplasmic organelles (88). At present, it is
not known whether lysosomal membrane
damage is due to chemical (by uranium) or
radiological toxicity (87). Moores et al.
(117) have shown that there is a significant
depression in the number ofmouse alveolar
macrophages after exposure to 239PuO2 at
initially acquired doses greater than 20 Bq.
Morgan and Talbot (116) reviewed diverse
effects of inhaled a-emitting actinides on
mouse alveolar macrophages. For example,
239PuO2 exposure appears to increase
macrophage size, inhibit the mobility of
macrophages, and enhance the phagocytic
capacity. Cytoplasmic and lysosomal
enzymes such as lactate dehydrogenase and
a-glucuronidase are also activated by
239PuO2. Induction of nuclear aberrations,
particularly micronuclei, can be detected at
doses as low as 1 Bq, corresponding to a
cumulative radiation dose to lung of 50
mGy (118).
Recent data suggest that there are two
distinct mechanisms involved in radiation-
induced radiation damage: 1) classical
pneumonitis, which ultimately leads to
pulmonary fibrosis, is primarily due to
radiation-induced local cytokine produc-
tion confined on the field ofirradiation; 2)
sporadic radiation pneumonitis, which is
an immunologically mediated process
resulting in bilateral lympholytic alveolitis
(119). Both animal experiments and
human studies show that classical radiation
pneumonitis has a threshold dose and a
narrow dose-response curve with increased
morbidity and mortality over a small dose
range (119). For example, in rats, inhala-
tion of high-fired 239PuO2 (initial lung
burden 3.9 kBq) leads to peribronchial par-
ticle aggregation, which increases with time
and results in well-defined focal inflamma-
tory lesions after 120 days (120). The exact
mechanisms of radiation pneumonitis
induced by insoluble radioactive particles
are not fully understood. One possible
mechanism is damage to type II cells, caus-
ing alterations in the cell differentiation
and disturbances in the metabolism ofsur-
factant phospholipids (121), or type II pro-
liferation with failure to develop into type I
cells (122). Taya et al. (123) have shown
that significant cellular changes, particular-
ly cell proliferation (mainly type II and
Clara cells), occur early after exposure of
mouse lung to 239PuO2 at initial alveolar
deposit of 500 Bq. However, the relevance
ofthe results to the late carcinogenic effects
of239PuO2 could not be verified because of
the limited duration ofthe study.
Effects of insoluble, internally deposit-
ed radionuclides on the pulmonary clear-
ance ofinhaled bacteria have been reported
in a few studies (124-126). For example,
inhalation exposure to insoluble 144CeO2
and 239PuO2 particles reduced the pul-
monary clearance of Staphylococcus aureus
in mice (124). The authors suggested that
direct radiation injury to the alveolar
macrophage population was the likely
cause ofthe reduced clearance (124). It has
also been shown that inhaled 144Ce in a
relatively insoluble form results in
detectable changes in the pulmonary sur-
factant, important in the killing ofbacteria
by pulmonary macrophages (127). These
studies indicated that insoluble radionu-
clides may decrease an animal's resistance
to bacterial invasion of the lungs and
increase the risk for pneumonitis. Studies
with simulated nuclear fuel particles (neu-
tron-activated U02) show that particles
induce local inflammatory changes at the
cumulative lung doses of 170, 230, 400,
and 550 mSv (97). As a short-term effect,
the particles also appeared to modulate the
cytochrome P450 enzyme activities, which
in turn may affect the metabolism and
effects ofxenobiotics and chemical carcino-
gens (128).
Pulmonary Fibrosis
Fibrosis-associated changes apparently have
their origin in the pneumonitic phase
(35,119,129). At the light microscope
level, fibrosis is defined as an increase of
connective tissue fibers as a result ofinade-
quate regeneration of parenchyma.
Collagen accumulation may alter the nor-
mal ratio of type I (coarse fibered) to type
III (meshwork) collagen. Cellular distur-
bances play an important role in the alter-
ations of the alveolar structure involving
cell death on the endothelial and epithelial
sides ofthe basement membrane and dam-
age to the immune-competent cells (130).
Biochemical and histological evidence of
fibrosis may be detected as early as 2
months after radiation exposure (129). Gas
transfer is impaired by fibrosis as a result of
thickening of alveolar-capillary barriers
and reduction in the effective surface area.
Recent studies have shown that irradiation
induces gene transcription and results in
the induction and release of proinflamma-
tory cytokines and fibroblast mitogens,
which ultimately results in pulmonary
fibrosis (119). Ionizing radiation may
induce synthesis of various inflammatory
gene products, such as EGRI (131),
platelet-derived growth factor (132), and
necrosis factors (133).
Studies with insoluble, fused alumi-
nosilicate particles carrying 90Y have
demonstrated a typical pneumonitic phase
in beagle dogs and lung function changes
typical of pneumonitis and fibrosis (134).
Inhalation of'44Ce fused clay particles have
shown an early increase in ultrafiltrable
hydroxyproline in the lungs of beagle dogs
(135), suggesting an increase in collagen
degradation, preceding the synthetic phase
of more soluble collagen. Beagle dogs may
have signs of restrictive lung disease 1-5
years after exposure by inhalation to
239PuO2 at initial pulmonary burdens of
330-4100 kB/kg of body mass (136).
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LaBauve et al. (93) observed marked alter-
ations in respiratory function in a Rhesus
monkey 30 days before its death from pul-
monary fibrosis 990 days after inhalation
exposure to 239PuO2 (estimated initial lung
burden 37000 Bq). Exposure of rats to
high-fired 239PuO2 (initial lung burden 3.9
kBq) resulted in fibrotic lesions 180 days
after inhalation (120). Some studies with
soluble and insoluble 239Pu particles have
shown that the metabolism ofcollagen, gly-
cosaminoglycans, and lipids in laboratory
animals are all shifted toward enhanced syn-
thesis (129). McAnulty et al. (137)
observed dramatic increases in both synthe-
sis and degradation rates ofcollagen in the
mouse lung after exposure to 239PuO2, sug-
gesting an extensive remodeling ofthe lung
connective tissue matrix during develop-
ment of fibrosis. Preexisting, bleomycin-
induced pulmonary fibrosis has been shown
to decrease significantly the clearance of
239PuO2 in the rat lung (138). However,
the risk oflung tumors in rats with orwith-
out existing pulmonary fibrosis were simi-
lar. Diel et al. (139) exposed beagle dogs to
239puO2 once (accumulated doses of23 ± 8
Gy) or repeatedly (22 ± 5 Gy during 7-10
semiannual exposures). Clearance ofpluto-
nium from the lungs of dogs exposed
repeatedly was slower than in the dogs
exposed once. Pulmonary fibrosis account-
ed for 72% of the radiation-related deaths
in the single-exposure study and 87% in the
repeated-exposure study. The remaining
dogs died from pulmonary cancer. The
dose rate did not appear to be an important
factor in predicting death from radiation
pneumonitis orpulmonary fibrosis.
Pulmonary Cancer
Tumors in the lung as a direct consequence
of inhalation or instillation of radioactive
materials are easily demonstrated in ani-
mals. However, in rodents, spontaneous or
radiation-induced tumors normally occur
in the alveolar region, whereas in man they
are located in the bronchiolar region (129).
Studies on Japanese A-bomb survivors and
American uranium miners have shown that
radiation-induced lung cancers appeared
more likely to be ofsmall-cell subtype and
less likely to be adenocarcinomas (140).
The review of lung cancer cases revealed
further that the proportion of squamous
cell cancer was positively related to smok-
ing history in both populations. Absolute
radiogenic risks of radiation-induced lung
cancers are similar for both sexes, although
baseline lung cancer risks are much higher
than they are for females (141). Other fac-
tors important in risk assessment of the
effects of radioactive particles in the lungs
involve the particle size, chemical and
physical form of the particles, the type of
radioactive emission, the physical half-life
of the radionuclide and its biological half-
time in the lungs. Animal experiments
indicate that prolongation of {-irradiation
of the lung from a period ofdays to years
reduces its tumorigenic effectiveness by a
factor ofabout 3, and that chronic a-irra-
diation of the lung from inhaled 230PuO2
is 10 to 20 times more carcinogenic than
chronic g-irradiation (141) Burkart (35)
has stated that both from the point ofview
ofcontracted dose and radiosensitivity, the
human lung is the most critical organ for
late somatic health effects from exposure to
ionizing radiation in our environment.
Alpha-emitters
Several animal studies have been performed
to study long-term effects of insoluble a-
emitters. Leach et al. (89,90) studied long-
term effects ofnatural U02 particles in the
monkey, dog, and rat. Inhalation of 1 pm
mass medium diameter particles at a mean
concentration of5 mg/mi3, (6 hr per day, 5
days per week) did not cause serious injury
in animals during the 5-year exposure. In
the following post-exposure period, malig-
nant tumors developed in 31% ofthe dogs
2-6 years after the exposure. The effects of
inhaled 238Pu/239Pu dioxides have been
studied in rats (104,142) , Syrian hamsters
(143), and mice (144). These studies
demonstrated, except for studies in mice,
that prolonged inhalation of insoluble cx-
emitters does not enhance pulmonary car-
cinogenesis as compared to a single expo-
sure. Both 238PuO2 and 239PuO2 have been
shown to cause malignant lung tumors in
dogs (139,145,170-173). Diel et al. (139)
exposed beagle dogs to 239PuO2 once and
repeatedly (7-10 semiannual doses) to
22-23 Gy lung doses by inhalation. In the
single exposure, 28% ofthe dogs died with
pulmonary cancer, whereas in the repeated
exposure the death rate was 13%. Gillett et
al. (146) also observed primary liver tumors
in beagle dogs exposed by inhalation to
239PuO2. In baboons, 239PuO2 particles
caused slightly differentiated lung carcino-
ma and bronchogenic adenoma (115).
Hahn et al. (147) also observed fibrosarco-
ma in the lung of a rhesus monkey after
Table 3. Summary ofselected experimental studies supporting or refuting the hot particle theory
Species Experimental design Tumor incidence Reference
Sprague-Dawley rats, male Single external B-irradiation ofskinwith Markedlydelayed aftergrid and sieve Albert etal., 1967(180)
91Y-source; grid, sieve, and uniform exposure nonuniform radiation exposure compared with
uniform exposure
CBN/H mice,female Single external B-irradiation ofskinwith Proportional tothe area ofirradiated skin Hulse, 1967(181);
204TI-source; irradiation over one ortwo zones Hulse etal., 1983(182);
Papworth and Hulse,
1983(183)
SAS/4mice Single external B-irradiation ofskin with 30% Reduction bythe32-pointarray atlow Williams etal., 1986(184);
17OTM source; uniform and arrays of doses; an order-of-magnitude reduction by Charles etal., 1988(185)
nonuniform 8 or32sources the 8-pointsource atlowdoses
Sprague-Dawley SPF rats Inhalation ofuniformlydistributed, soluble Uniformlydistributed244Cm-(NO3)3 upto 5times Lafuma etal., 1975(152)
244Cm(N-03)3, and particulate 239Pu02 moretoxicthan239PuO2
(hotparticle model)
Syrian golden hamsters Repeated intratracheal instillation ofa-active Incidence nearlysimilarin both experiments Little and O'Toole, 1974(11)
210Po absorbed onto Fe203 particles orin
0.9% NaCI solution (more uniform distribution)
C3H 10T1/2 cells Irradiation of cellswith Chernobyl-released and Malignanttransformation in each cell culture; Servomaa and Rytomaa
simulated nuclearfuel particles expected incidence 0% 1989,1990(17,18);
Servomaa etal., 1992(19)
Hairless mice Implantation ofsimulated nuclearfuel particles Incidence about10% in exposed sites; Lang etal., 1993(20);
underthe dorsal skin expected incidence0% Leszczynski etal., 1994(21)
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inhalation of 239PuO Sanders and co-
workers (99,148,1459) exposed Wistar rats
to 239PuO2 aerosol. Survival was signifi-
cantly reduced only in rats with lung doses
>30 Gy. Ninety-nine primary lung tumors
were found out of the 2105 exposed ani-
mals, of which 92% were malignant and
80% carcinomas. The authors suggested
that all types of malignant lung tumors
exhibited a threshold at a lung dose >1 Gy
(149). No significant difference was
observed in nonpulmonary tumor location
or type between control and exposed rats
(148). Studies on plutonium-induced pul-
monary neoplasms in the rat suggest that
the alveolar epithelial surface may be more
at risk for neoplasic transformation than the
other histological types of proliferative foci
(150). The majority of plutonium-induced
proliferative epithelial lesions and neo-
plasms in the rat appear to originate from
alveolar type II pneumocytes (151).
Little and O'Toole (11) studied the
effects ofnonhomogeneously and uniformly
distributed 210po on the hamster lung. The
average macroscopic dose to the lung was
about 200 Sv. Tumor incidence was higher
in the animals exposed to 210po in solution
than in animals exposed to 21OPo bound to
Fe203 particles with nonuniform dose dis-
tribution (see also Table 3). Nonuniform
irradiation also resulted in longer latency
periods. Lafuma et al. (152) exposed rats to
soluble, uniformly distributed
244Cm(NO )3 and insoluble 239PuO2)
which served as a model for hot particles.
Uniformly distributed 244Cm(NO3)3 was
up to five times more toxic than particulate
2J9PuO2 (Table 3). Most inhalation studies
with relatively insoluble a-emitters appear
to produce lung cancers in rats, mice, and
dogs at initially acquired doses above 0.04
Mbq/kg, with peak incidences in the range
of0.6-3.7 MBq/kg (129). Recent studies by
Lundgren et al. (153) have shown that the
relative biological effectiveness in rats ofthe
a-particle doses to the lungs from inhaled
239PuO2 relative to fl-particle doses to the
lungs from inhaled '44CeO2 is 21 ± 3.
Beta-emitters
Most experiments with f3-emitters have
involved studies with compounds of 144Ce
in rats (113,154,155), mice (156,151), and
Syrian hamsters (158). In hamsters and
rats, the incidences ofprimary lung tumors
were more dependent on the cumulative fI-
radiation doses to the lungs than the radia-
tion dose-rate pattern. For example, in rats,
a mean life time dose of250 Gy resulted in
91.9% incidence of malignant lung
tumors, whereas a 50 Gy dose caused 27%
tumor incidence (131). The most frequent-
ly occurring malignant tumors were adeno-
carcinomas and squamous cell carcinomas.
Even neutron-activated U02 particles
induce benign or malignant tumors in rat
lung at cumulative 24-month lung doses of
0.4-0.66 Gy (128,159). Squamous cell car-
cinoma and adenocarcinoma are the most
frequently occurring tumors in the rat lung
after exposure to fl-irradiation (155,160).
The incidence of primary lung tumors in
rats is a slow process and appears to be
related to the cumulative f-radiation dose.
In mice, protraction of the absorbed dose
resulted in a sparing from the life-shorten-
ing effects of 144Ce pulmonary irradiation
(156). Seventy-day-old mice were more
sensitive to development of late-occurring
effects of inhaled 144CeO2 than 260- and
450-day-old mice. Experiments on beagle
dogs have shown that protracted irradia-
tion of the lungs with 144Ce or 90Sr result
in a relatively high radiation dose and pro-
duce more total lung tumors but fewer
lung tumors per Gray than less protracted
irradiation with 90Y and 91Y (161). The
carcinomas included adenocarcinomas,
squamous cell carcinomas, or combinations
of these types. Hemangiosarcomas were
induced in animals that were exposed to
144Ce and 90Sr but were not found after
90Y or 91y exposures; this tumor type was
not even found in earlier inhalation expo-
sure of beagle dogs to 239PuO2 (162).
Boecker et al. (163) exposed beagle dogs
once, briefly, by inhalation, to the fi-emitter
91y or to the a-emitter 239PuO2. 239PuO2
was more effective in producing lung cancer
than was 91Y; risk coefficients for 239Pu/91Y
ranged from 10 to 18.
Molecular Mechanisms ofLung
Carcinogenesis Induced byInsoluble
Nuclear Fuel Particles
The conversion of lung cells from normal
to malignant involves a series of molecular
changes, including the inactivation of
tumor suppressor genes, the activation of
dominant oncogenes, or other disturbances
in normal cellular processes (164). The p53
tumor-suppressor gene appears to have a
central role even in radiation-induced neo-
plasms of the lung. For example, p53
mutations have been observed in lung
tumors of miners exposed to radon
(165,166) and in lung cancers from radia-
tion-exposed and nonexposed atomic-
bomb survivors from Hiroshima (162).
Molecular changes in the lungs associ-
ated with radiation carcinogenesis after
exposure to insoluble nuclear fuel particles
are not well understood. However, the p53
tumor suppressor gene appears to have a
central role even in radiation lung carcino-
genesis induced by insoluble nuclear fuel
particles. We observed both overexpression
and mutations in the p53 gene in malig-
nant tumors in the rat lung after exposure
to neutron-activated U02 particles (159).
The base change was identical in each case.
Transition ofC:G to T:A in the CG dinu-
cleotide as a result of low-LET radiation
may be similar to CC to TT double-base
change in UV-associated skin cancer
(168,169) or AGG to ATG transversion in
high-LET-radiation related lung cancer
(166).
Some studies have also been performed
to investigate molecular mechanisms in the
lungs after exposure to 239PuO2. The
expression of epidermal growth factor
receptor (EGFR) was detected in plutoni-
um-induced lung neoplasms in dogs (170).
Forty-seven percent of lung tumors
expressed EGFR; however, the expression
was not correlated with tumor etiology
(e.g., spontaneous versus radiation-
induced), but did correlate with specific
histologic phenotypes. The same group
(171) observed an increased (59%) expres-
sion of transforming growth factor-a
(TGF-a) in plutonium-induced lung neo-
plasms in the dog. Twenty-seven percent
(32/117) of radiation-induced proliferative
epithelial foci expressed TGF-a, and many
of these foci (8/32) expressed both EGFR
and TGF-a. The results indicated that the
foci exhibiting increased expression of the
growth factor or its receptor represented
preneoplastic lesions which were at greater
risk for progression to neoplasia. Even a
significant increase in EGFR binding has
been observed in plutonium-induced dog
lung tumors (172). Davila et al. (173) have
also observed severe depression ofimmune
response in tumor-bearing beagle dogs
which had been exposed to 2 9pUO2.
Overexpression ofTGF-a and EGFR have
also been observed in plutonium-induced
malignant tumors in rat (174). These data
suggested that increased amounts ofTGF-
a were early alterations in the progression
ofplutonium-induced squamous cell carci-
noma, and the increases may occur in par-
allel with overexpression ofthe receptor for
this growth factor.
Stegelmeier et al. (175) have also inves-
tigated molecular and genetic alterations of
Ki-ras in preneoplastic foci and neoplasms
in the lungs of rats that had inhaled
239PuO2. Specific Ki-ras point mutations
were present in 46% of the radiation-
induced malignant neoplasms. Similar
mutation frequencies were observed in
radiation-induced adenomas and foci of
alveolar epithelial hyperplasia, but no
mutations were identified in normal lung
tissue. The findings suggested that Ki-ras
activation, not alterations in expression, is
an early lesion associated with many radia-
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tion-induced, proliferative pulmonary
lesions and that this molecular alteration
may be an important component of both
radiation-induced and spontaneous pul-
monary carcinogenesis in the rat.
Biological Effects of
Nonuniform Radiation on the
Skin
Acute Effects
The response ofthe skin to ionizing radia-
tion is highly complex and depends to a
large extent on the exposure conditions
(176). The basic underlying pathogenic
mechanisms following hot particle expo-
sure appear to be different from classical
radiation damage to skin. The primary
lesion resulting from irradiation with hot
particles is acute ulceration (176). The
depth and size ofthe ulcer depends on the
skin surface dose and the energy of the
radiation from the particle. Before the
development of an ulcer, a small pale, cir-
cular area with a slight bluish tinge can be
detected, which is frequently surrounded
by a halo of erythema. Within a few days
of irradiation, pyknosis of nuclei of
endothelial cells and fibroblasts can be seen
in the papillary dermis, and within 5-7
days the papillary dermis is largely without
cell nuclei. These changes result from the
direct cell death ofthese cells in interphase
after doses >100 Gy. Acutely produced
ulcers of the skin tend to heal rapidly if
they do not become infected, and the
lesion leaves a small scar with the appear-
ance ofa small dimple (20,176).
The ED50 (effective dose) values for
acute ulceration from 90Sr/90Y and thulli-
um-170 (170Tm) particles <1 mm in diame-
ter is about 250 Gy (17X). Moist desqua-
mation cannot be seen after hot particle
irradiation, but late dermal atrophy may
develop at doses below the threshold for
ulcer formation (178). Lang et al. (20)
exposed hairless and nude mice to neutron-
activated U02 particles. Within the first
two weeks, an ulcer (diameter 1-4 mm)
with erythematous and thick edges devel-
oped. At about 3 weeks, the hyperplastic
epidermis often had a papillomalike appear-
ance. Histologically, a five- to sixfold
increase in epidermal thickness was
observed. Inflammatory and giant cells of
foreign body type were seen in the dermis It
is currently believed (14,15) that the only
type of hot particle-induced lesion of con-
cern is acute ulceration or breakdown with
subsequent infection leading to ulceration.
Carcinogenesis
Ionizing radiation is a complete carcinogen
(i.e. initiator and promotor), in rodent skin
(15). In rats and mice, and in humans, the
times between irradiation and appearance of
tumors, as fractions of life span of the
species, is similar. Protraction of radiation
dose produces a reduction in its carcino-
genicity in rats, whereas in mice no sparing
effect has been observed. The human data
support asignificantlylower skin cancer inci-
dence, at least two orders ofmagnitude lower
than that in rodents (179). Some ofthis dis-
crepancy may be because the human tumors
are mostly basal cell carcinomas, whereas
only a few radiation-induced cancers in the
experimental animals are ofthis type.
Most of the long-term studies on skin
carcinogenesis after hot particle exposure
have refuted the hot particle theory (Table
3). Albert et al. (180) showed that the rat
skin tumor yield after grid and sieve
nonuniform radiation exposure was
markedly delayed compared with uniform
exposure. Hulse and colleagues (181-183)
irradiated CBA mice with thallium-204
(204T1) particles using 12 different surface
doses (5.4-260 Gy) and 4 different dose
rates (1.7-200 cGy/min). The average
latent period for tumor formation was 7
months, and more than 70% ofthe tumors
were ofdermal origin, 30% epidermal, and
more than 60% were malignant. The
tumor yield was proportional to the area of
skin irradiated (182). Williams and his col-
leagues (184,185) exposed 1200 SAS/4
mice to uniform 170Tm-sources (8.6 cm2)
and nonuniform 170Tm sources, which
were arrays ofeither 32 or 8 sources, each 2
mm in diameter, distributed over 8 cm2.
Average skin doses varied from 2-100 Gy.
The nonuniform irradiation showed a 30%
reduction in tumor incidence by the 32-
point array at the lower mean doses com-
pared with the response from uniform
sources. The 8-point array showed an
order-of-magnitude reduction in tumor
incidence compared to uniform irradiation
at low doses. Even national and interna-
tional radiation protection organizations
have stated their objection to the hot parti-
cle theory (14,15).
Our current observations (20,21) do
not agree with the previously reported
results. We exposed hairless and nude mice
to neutron-activated U02 particles by
implanting the particles under the skin,
which permitted a continuous long-term
exposure of the skin to hard 9l-irradiation.
The results suggested that there was an
excess of skin cancers in mice exposed to
hot particles compared with the numbers
estimated using a conventional, nonthresh-
old stochastic model of radiation-induced
cancer (see Table 3). The results ofthe pre-
vious studies have undoubtedly been cor-
rect, but the conclusions have been too
generalized. The results in our studies
showed further that any direct mathemati-
cal-statistical extrapolation is not always
appropriate but requires judgmental evalu-
ation ofbiological mechanisms.
Biological Mechanisms ofSkin
Carcinogenesis Induced by Hot
Particles
Development of skin cancer has been
shown to be associated with the activation
of many genes, particularly oncogenes and
tumor-suppressor genes. Current evidence
indicates that carcinogenesis is a multistep
process (186,187). Activation of ras (188)
and c-myc oncogenes (188,189) has been
observed in radiation-induced skin tumors
in rats. Overexpression of ras oncogenes
has been found in many preneoplastic
tumors, suggesting that ras activation is
often an early event in tumor formation
(187). Biopsy studies have shown that in
radiation-induced rat skin tumors, c-myc
functions as a late-stage progression-related
oncogene (189). Physical parameters such
as LET, dose, and dose rate may also affect
oncogene activation patterns (190).
Our observations (20,21) suggest that
the development of hot-particle-induced
skin cancer depends on a few essential cel-
lular and molecular mechanisms. The
development of a permanent wound is an
essential step in the carcinogenesis induced
by nonuniform n-irradiation. The wound
acts as a promoter by stimulating the pro-
liferation of surrounding mutated cells.
The skin exposure to simulated nuclear fuel
particles revealed further that expression of
p53 tumor-suppressor protein was frequent
(28%) at the exposed sites (21). In some
cases p53 protein was detected not only in
the nucleus but also in the cytoplasm ofthe
epithelial cells. The expression ofthe onco-
proteins p62c'fos and 21N-ras was also
markedly elevated in all the p53-expressing
skin samples. The results showed that
apparent carcinogenesis-related molecular
changes occur frequently in the mouse skin
well before the development of a distinct
tumor, and probably even before premalig-
nant changes can be detected by conven-
tional histopathological analysis.
The key feature in carcinogenesis is that
an agent can increase the incidence ofcan-
cer in one of two ways: it can specifically
damage the DNA in a cell or increase the
number ofcell divisions, thereby providing
a greater opportunity for (spontaneous)
genetic errors during DNA replication
(191). In hot particle exposure, both mech-
anisms are simultaneously involved and,
possibly even more important in view of
the multistage model ofcarcinogenesis, the
number of cell divisions is increased in the
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same cells in which specific radiation-
induced DNA damage is most likely to
occur. Our in vivo studies (20,21) directly
support the general multistage model of
carcinogenesis according to which the
mechanism is based on genotoxic (DNA
damage) and nongenotoxic (cell prolifera-
tion) effects. These observations are also
supported by our in vitro experiments
where C3HIOTI/2 cells were exposed to
Chernobyl-released and simulated nuclear
fuel particles (17-19). Malignant foci
developed in all cell cultures usually 2-4
mm from the radiation source. In addition,
almost all the tested 11 oncogenes were
activated by radiation, though in none of
them was this change common.
Conclusions
Environmental releases ofinsoluble nuclear
fuel particles may occur both in nuclear
power plants in normal operation and fol-
lowing nuclear power plant accidents. The
effects of hot particles on humans have
been assessed in a few epidemiological and
theoretical studies based on occupational
exposure to PuO2 particles and exposure to
Chernobyl-released uranium particles. The
results have so far been only speculative
due to the lack ofdetailed and reliable data
on the exposure. However, the biokinetics
and biological effects of nuclear fuel com-
pounds have been investigated in a number
ofexperimental studies using various cellu-
lar systems and laboratory animals.
Ingestion ofinsoluble nuclear fuel com-
pounds does not pose a serious radiological
health problem. U02 and PuO2 particles
are not absorbed to any significant extent
from the GI tract ofexperimental animals.
Fission products 144Ce, 141Ce, 103RU, 95Zr,
and 95Nb are also absorbed poorly in their
elementary form, whereas they are almost
metabolically inert in the fused particulate
form in the uranium matrix. However, in
neonatal animals the absorption is higher.
Aslight retention ofcompounds may occur
in the intestinal cells, but only extensive
amounts ofnuclear fuel material with pro-
longed retention in the GI tract may cause
serious lesions in the radiosensitive cells
crypt cells ofthe intestine.
Inhalation of insoluble nuclear fuel
compounds induce both benign and malig-
nant lung tumors in experimental animals.
The elevated cancer risk is due to the long
retention ofparticles in the lower respirato-
ry tract. However, both intratracheal instil-
lation and inhalation of insoluble nuclear
fuel particles seems to lead to a nonuni-
form distribution of particles in the lungs
and therefore complicates the assessment of
the lung cancer risk based purely on the
conventional dose calculations. Trans-
location of PuO and U02 particles and
fission products 1A4Ce, 141Ce, 103Ru, 95Zr,
95Nb in the particulate form from the
lungs to other organs or tissues is poor.
The development of hot particle-
induced cancer has been investigated in a
number of experimental and theoretical
studies. Most ofthe studies have suggested
that nonuniform distribution of ionizing
radiation is less carcinogenic than the same
amount ofradiation delivered uniformly to
the same organ or tissue. However, current
observations indicate that the development
of a permanent wound is an essential step
in carcinogenesis induced by nonuniform
f9-irradiation. This is also the primary
lesion in the skin resulting from hot parti-
cle irradiation. The wound acts as a pro-
moter by stimulating the proliferation of
surrounding mutated cells. The experimen-
tal design in most of the studies has not
allowed the development of a permanent
wound, which in part may explain the
obvious discrepancy between the results. In
addition, the contradictory results can also
be explained by the different effects of
nonuniform a- and f-irradiation on bio-
logical material.
Exposure to insoluble nuclear fuel parti-
cles may induce various changes at the mol-
ecular level, which can be observed long
before the development of a tumor.
Overexpression and mutations ofgenes reg-
ulating cell proliferation and cell growth
have been observed both in vitro and in
vivo. The tumor-suppressor gene p53 may
play a central role even in carcinogenesis
induced bynonuniform radiation exposure.
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